Related Experiment Video
Updated: Feb 28, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
The NCI Genomic Data Commons as an engine for precision medicine
Mark A Jensen1, Vincent Ferretti2, Robert L Grossman3
1Leidos Biomedical Research, Inc., Frederick, MD.
The National Cancer Institute Genomic Data Commons (GDC) provides a centralized system for cancer genomic and clinical data. It addresses big data challenges to advance precision medicine in cancer diagnosis and treatment.
Area of Science:
- Genomics
- Bioinformatics
- Oncology
Background:
- High-throughput sequencing generates vast cancer genomic and transcriptome data.
- Big data challenges hinder cancer researchers and clinicians from extracting actionable insights.
- Understanding the link between tumor genomics and treatment response is crucial.
Purpose of the Study:
- To establish the National Cancer Institute Genomic Data Commons (GDC).
- To create an information system for storing, analyzing, and sharing cancer genomic and clinical data.
- To democratize access to cancer data and promote precision medicine.
Main Methods:
- Development of a comprehensive data storage and analysis information system.
- Implementation of data sharing protocols to facilitate collaborative research.
- Integration of genomic and clinical data for holistic patient analysis.
Main Results:
- The GDC provides a unified platform for large-scale cancer genomic data.
- Facilitates access to data for a wider range of cancer biologists and oncologists.
- Enables deeper insights into cancer biology and treatment efficacy.
Conclusions:
- The GDC democratizes access to critical cancer genomic information.
- Supports the advancement of precision medicine through data sharing.
- Empowers researchers and clinicians to better understand and treat cancer.
More Related Videos
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Genomics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...